Clinical data available for HCC and CCA tumors included immune subtype classifications for wound healing (C1), IFN-gamma dominant (C2), inflammatory (C3), and lymphocyte depleted (C4) subtypes. The gene discussed is IFNG; the disease is hepatocellular carcinoma.